Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bexarotene and Tretinoin with Chemotherapy in Advanced NSCLC
NCT00514293Phase 2Unknown
- Sponsor
- Raghu Nandan, M.D.
- Start
- Jan 2007
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of bexarotene in non-small cell lung cancer (NSCLC), sponsored by Raghu Nandan, M.D.. Status: unknown.
02
Drugs
bexarotene
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00514293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00514293.